Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO > PEER COMPARISON
Peer Comparison      
Zydus Lifesciences Ltd.
Peer CompaniesPrice(Rs)Chg(Rs) Chg(%)EPS(Rs.)TTM P/EVolume(000's)1Year Return(%)Divinded YieldBook Value
Mercury Laboratories 980 89.95 10.11 33.24 26.78 0-18.94 0.39 423.65
Alkem Laboratories 5660 75.15 1.35 176.48 31.65 09.14 0.72 882.86
Supriya Lifescience 835 56 7.19 19.57 39.8 0155.55 0.1 101.31
Wockhardt 1499.55 53.8 3.72 -14.16 0 0210.02 0 115.78
Mankind Pharma 2950 50.45 1.74 49.15 58.99 040.27 0 239.66
Ipca Laboratories 1789 45.75 2.62 25.62 68.05 060.78 0.23 250.24
Innova Captab 1179.7 40 3.51 15.08 75.56 0108.65 0 126.47
Caplin Point Lab 2599.5 39.45 1.54 39.94 64.09 086.5 0.2 181.16
Astrazeneca Pharma I 7174 36.25 0.51 32.77 217.83 025.98 0.34 283.45
Sun Pharma Inds. 1905 27 1.44 11.21 167.51 046.95 0.72 98.76
Shilpa Medicare 860 26.25 3.15 7.29 114.39 0164.62 0 246.85
Natco Pharma 1410 24.65 1.78 102.65 13.5 071.85 0.69 312.42
Advanced Enzyme 378 23.85 6.73 8.8 40.25 01.18 1.44 51.64
Coral Laboratories 828 23.3 2.9 64.74 12.43 093.5 0.25 496.83
Strides Pharma Scien 710 20.65 3 8.18 84.22 05.11 0.36 387.16
Gland Pharma 1860.2 17.7 0.96 66.94 27.52 0-5.91 1.09 546.04
Torrent Pharma 3460 13.75 0.4 48.34 71.29 049.03 0.81 201.76
Cipla 1550 12.45 0.81 52.42 29.33 020.95 0.85 345.95
Aarti Pharmalabs 704 12.05 1.74 22.75 30.41 039.67 0.43 178.89
Glenmark Pharma 1650 11.05 0.67 199.94 8.2 085.78 0.15 813.92
Page 1 of 5 Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.